TTD | Drug: D0C3MW

Drug General Information
Drug ID	D0C3MW
Former ID	DIB001027
Drug Name	MBO7133
Indication	Liver cancer [ICD9: 140-229, 155, 203.0; ICD10:C22]		Phase 1/2	[549973]
Company	Metabasis Therapeutics Inc
Target and Pathway
Target(s)	Human DNA	Target Info	Binder	[550613]
References
Ref 549973	Clinical pipeline report, company report or official report of Metabasis Therapeutics (2006).
Ref 550613	Novel Cox-2 Inhibitor for Breast Cancer Therapy. Temple University School of Medicine Philadelphia, Pennsylvania 19140. July 2004.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.

Drug Information